Fudosteine
福多司坦
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameFudosteine
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2001/10/01
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMitsubishi Tanabe Pharma
China Registration ClassN/A
Develop Information
Active CompaniesMitsubishi Tanabe Pharma
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksKEGG